Malaysian Consensus Statement for the Diagnosis and Management of Acromegaly

Zanariah Hussein; Mohamed Long Bidin; Azmi Alias; Muthukkumaran Thiagarajan; Kartikasalwah Abdul Latif; Jeyakantha Ratnasingam; Wan Juani Wan Seman; Azraai Nasruddin

doi:10.15605/jafes.034.01.03

Malaysian Consensus Statement for the Diagnosis and Management of Acromegaly

J ASEAN Fed Endocr Soc. 2019;34(1):8-14. doi: 10.15605/jafes.034.01.03. Epub 2019 May 28.

Authors

Zanariah Hussein¹, Mohamed Long Bidin², Azmi Alias², Muthukkumaran Thiagarajan², Kartikasalwah Abdul Latif², Jeyakantha Ratnasingam³, Wan Juani Wan Seman¹, Azraai Nasruddin¹

Affiliations

¹ Hospital Putrajaya, Malaysia.
² Hospital Kuala Lumpur, Malaysia.
³ University of Malaya, Kuala Lumpur, Malaysia.

Abstract

In Malaysia, acromegaly is under-recognised with only 10-15% of the expected number of cases from prevalence estimates, having been diagnosed and managed in established endocrine centres with access to multidisciplinary care. This is mainly due to lack of awareness and standardised approach in diagnosing this disease resulting in delay in diagnosis and management with suboptimal treatment outcomes. This first Malaysian consensus statement on the diagnosis and management of acromegaly addresses these issues and is based on current best practices and latest available evidence so as to reduce the disease burden on acromegaly patients managed in the Malaysian healthcare system.

Keywords: Malaysia; acromegaly; consensus; growth hormone excess.